Search

everythinglearnresearchcommunity

for

Search:↓

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

MFN2 mutations cause mitochondrial problems, leading to more upper body fat and lower leptin levels.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

A woman's high testosterone levels and related symptoms improved after ovary removal surgery.

Older men with low levels of a testosterone byproduct had a higher chance of developing an irregular heartbeat.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

Men with male pattern baldness are more likely to have unhealthy blood lipid levels, which could signal other health issues.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

Many women with polycystic ovary syndrome have normal blood sugar, but some may have higher blood sugar levels or diabetes, especially if they are older, overweight, and have certain hormone levels.

Psoriasis, acne, and hair loss are linked to unhealthy cholesterol levels, increasing heart disease risk.

Androgenetic alopecia is linked to higher cardiovascular and metabolic risks, possibly due to irisin resistance.

Androgenetic alopecia may be linked to metabolic syndrome.

People with cutaneous Lichen Planus are more likely to have Metabolic Syndrome and related conditions like high cholesterol, diabetes, and high blood pressure.

People with androgenetic alopecia have a higher risk of metabolic syndrome.

MFN2 mutations cause mitochondrial problems, unusual fat distribution, and low leptin despite high body fat.

Diagnosing and treating PCOS in teenagers is difficult, and the focus is on lifestyle changes and medication to improve health and prevent future issues.

Nourkrin® with Marilex® may significantly increase hair growth and alopecia could be an early sign of metabolic syndrome.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Some women with PCOS have rare genetic variants linked to the condition.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Methylated flavonoids may effectively reduce depression and inflammation caused by finasteride.

PCOS is managed by lifestyle changes and personalized medication to improve symptoms and fertility.

Low HDL-C, uric acid, and 25-hydroxyvitamin D are risk factors for early-onset male hair loss.

A woman's virilization symptoms were caused by her partner's use of testosterone cream, which resolved after they separated.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

Certain metabolites can either protect against or increase the risk of hair loss.